ABSTRACT
Skin infections often develop in children, immunosuppressed patients, and patients with chronic conditions such as diabetes. Commonly encountered cutaneous infections are described herein, and treatments are briefly discussed. Photographs of infections provide assistance with differential diagnosis.
Subject(s)
Skin Diseases, Infectious/diagnosis , Soft Tissue Infections/diagnosis , Child , Chronic Disease , Diagnosis, Differential , Humans , Immunocompromised Host , Skin Diseases, Infectious/immunology , Soft Tissue Infections/immunologyABSTRACT
Lack of standardized rosacea nosology was the rationale for the National Rosacea Society to convene a committee of dermatology thought leaders to develop a standard classification system. Standardization of rosacea classification should be followed by standardization of treatment. Many pharmacologic and nonpharmacologic interventions for rosacea are being used based on clinical observation alone. Many oral and topical pharmacologic agents, however, are validated by randomized controlled trials (RCTs). Topical therapies (eg, metronidazole or an alternative agent such as azelaic acid) and oral antibiotics (eg, the tetracycline family) should remain as foundation therapies for subtypes 1 and 2 rosacea, based on the strength of the evidence.
Subject(s)
Rosacea/classification , Rosacea/therapy , Diagnosis, Differential , Evidence-Based Medicine , Humans , Randomized Controlled Trials as Topic , Rosacea/diagnosisABSTRACT
The roundtable discussion encompassed many topics-from seminal research by Ronald Marks to the latest National Rosacea Society-funded studies on the pathophysiology of rosacea. All participants commented on the value of the new National Rosacea Society classification system for subtypes of rosacea, designed to direct future research and help physicians better diagnose and manage these subtypes. A lively discussion centered on treatment options for the various subtypes of rosacea ensued.
